Floating dosage forms to prolong gastro-retention-The characterisation of calcium alginate beads

International Journal of Pharmaceutics

Volumn 350, Issue 1-2, 2008, Pages 301-311

  Stops, Frances ^a   Fell, John T ^b   Collett, John H ^b   Martini, Luigi G ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Citric acid; Dissolution release profile; Floating dosage forms; Gastro retentive dosage form; In vitro release; Riboflavin; Zero order

Indexed keywords

CALCIUM ALGINATE; RIBOFLAVIN;

ARTICLE; CONFOCAL LASER MICROSCOPY; DRUG DOSAGE FORM; DRUG RELEASE; DRUG SOLUBILITY; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; PHOTOGRAPHY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY;

ALGINATES; DRUG DELIVERY SYSTEMS; GLUCURONIC ACID; HEXURONIC ACIDS; HYDROGEN-ION CONCENTRATION; MATHEMATICS; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, SCANNING; PHOTOGRAPHY; RIBOFLAVIN; SOLUBILITY; STOMACH;

EID: 38349161002     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.09.009     Document Type: Article

References (28)

1. Axelrod D., Koppel D.E., Schlessinger J., Elson E., and Webb W.W. Mobility measurement by analysis of fluorescence photobleaching recovery kinetics. Biophys. J. 16 (1976) 1055-1069
2. British Pharmacopoeia, 2004, vol. IV. The Stationary Office, London (Appendix I).
3. Bussemer T., Peppas N.E., and Bodmeier R. Evaluation of the swelling, hydration and rupturing properties of the swelling layer of a rupturable pulsatile drug delivery system. Eur. J. Pharm. Biopharm. 56 (2003) 261-270
4. Chambers J.A.A., and Rickwood D. Biochemistry Labfax (1993), Blackwell Scientific Publications pp. 1-35
5. Colombo P. Swelling-controlled release in hydrogel matrices for oral route. Adv. Drug Deliv. Rev. 11 (1993) 37-57
6. Conte U., Colombo P., Gazzaniga A., Sangalli M.E., and La Manna A. Swelling-activated drug delivery systems. Biomaterials 9 (1998) 489-493
7. Efentakis M., Vlachou M., and Choulis N.H. Effects of excipients on swelling and drug release from compressed matrices. Drug Dev. Ind. Pharm. 23 (1997) 107-112
8. El-Gibaly I. Development and in vitro evaluation of novel floating chitosan microspheres for oral use: comparison with non-floating chitosan microspheres. Int. J. Pharm. 249 (2002) 7-21
9. Fassihi R. A novel device in conjunction with paddle method to replace the application of wire helix sinker to floating dosage form. Pharm. Res. 12 (1995) 298
10. Kelco International Limited. Alginate Properties for Scientific Water Control. third ed. (1987), Kelco International Limited, San Diego pp. 1-9
11. Klokk T., and Melvik J.E. Controlling the size of alginate gel beads by use of a high electrostatic potential. J. Microencapsul. 19 (2002) 415-424
12. Kubitscheck U., Wedekind P., and Peters R. Lateral diffusion measurement at high spatial resolution by scanning microphotolysis in a confocal microscope. Biophys. J. 67 (1994) 948-956
13. Melia C.D., Rajabi-Siambhoomi A.R., Hodson A.C., Adler J., and Mitchell J.R. Structure and behaviour of hydrophilic matrix sustained release dosage forms: 1. The origin and mechanism of formation of gas bubbles in the hydrated surface layer. Int. J. Pharm. 100 (1993) 263-269
14. Nykänen P., Lempää S., Aaltonen M.-L., and Jurjenson H. Citric acid as an excipient in multiple unit enteric coated tablets for targeting drugs on the colon. Int. J. Pharm. 229 (2001) 155-162
15. Østberg T., and Graffner C. Calcium alginate matrices for oral multiple unit administration. I: Pilot investigations of production method. Acta Pharm. Nord. 4 (1992) 201-208
16. Pillay V., and Fassihi R. Evaluation and comparison of dissolution data derived from different modified release dosage forms: an alternative method. J. Control. Release 55 (1998) 45-55
17. Puttipipatkhachorn S., Nunthanid J., Yamamoto K., and Peck G.E. Drug physical state and drug-polymer interaction on drug release rate from chitosan matrix films. J. Control. Release 75 (2001) 143-153
18. Singh B.N., and Kim K.H. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J. Control. Release 63 (2000) 235-259
19. Skaugrud Ø., Hage A., Borgerson B., and Dornish M. Biomedical and pharmaceutical applications of alginate and chitosan. Biotechnol. Genet. Eng. Rev. 16 (1999) 23-40
20. Stops F., Fell J.T., Collett J.H., Martini L.G., Sharma H.L., and Smith A.-M. The use of citric acid to prolong the in vivo gastro-retention of a floating dosage form in the fasted state. Int. J. Pharm. 308 (2006) 8-13
21. Stops F., Fell J.T., Collett J.H., Martini L.G., Sharma H., and Smith A.-M. Citric acid prolongs the gastro-retention of a floating dosage form and increases bioavailability of riboflavin in the fasted state. Int. J. Pharm. 308 (2006) 14-24
22. Streubel A., Siepmann J., and Bodmeier R. Floating matrix tablets based on low density foam powder: effects of formulation and processing parameters on drug release. Eur. J. Pharm. Sci. 18 (2003) 37-45
23. Timmermans, J., 1991. Floating hydrophilic matrix dosage forms for oral use. Factors controlling their buoyancy and gastric residence capabilities. Ph.D. Thesis. Free University of Brussels, Belgium.
24. Timmermans, J., Moës, A.J., 1989. Determining in vitro the resultant-force acting on a pharmaceutical form immersed in a fluid, an apparatus and a method. Proceedings of the Fifth APGI International Conference on Pharmaceutical Technology, Part 2, pp. 294-303.
25. Timmermans J., and Moës A.J. Measuring the resultant-weight of an immersed test material: I. Validation of an apparatus and a method dedicated to pharmaceutical applications. Acta Pharm. Technol. 36 (1990) 171-175
26. Timmermans J., and Moës A.J. How well do floating dosage forms float. Int. J. Pharm. 62 (1990) 207-216
27. US Department of Health and Human Services FDA, CDER, August 1997. Guidance for Industry. Dissolution testing of immediate release solid oral dosage forms.
28. Whitehead, L., 1998. An investigation into a gastroretentive dosage form. PhD Thesis. University of Manchester.